Welcome to our dedicated page for National Health SEC filings (Ticker: NHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
National HealthCare Corporation’s filings rarely stop at numbers—they reveal how Medicare rate shifts, facility occupancy, and labor costs shape one of America’s largest post-acute care networks. If you have ever asked, “How do I track National HealthCare Corporation insider trading Form 4 transactions?” or searched for a “National HealthCare Corporation quarterly earnings report 10-Q filing,” this page brings every disclosure together—with context that matters.
Stock Titan’s AI reviews each 10-K, 10-Q, 8-K, proxy, and Form 4 within seconds of its EDGAR release. Our summaries turn intricate reimbursement footnotes into plain language, so understanding National HealthCare Corporation SEC documents with AI becomes straightforward. Need real-time alerts? We surface each National HealthCare Corporation Form 4 insider transactions real-time alongside concise commentary on buying or selling trends.
Here is what you will uncover:
- Annual report 10-K simplified: drill into facility occupancy, CMS revenue exposure, and lease commitments without scanning 300 pages.
- Quarterly earnings report filing analysis: compare therapy hours, wage inflation, and cash flow quarter over quarter.
- 8-K material events explained: instant clarity on acquisitions, rate updates, or pandemic-related guidance changes.
- Executive stock transactions Form 4: see whether leadership is accumulating or trimming shares.
- Proxy statement executive compensation: evaluate pay-for-performance metrics tied to occupancy and quality ratings.
Whether you monitor dividend sustainability or compliance risk, our platform keeps National HealthCare Corporation SEC filings explained simply. Save research hours, spot trends earlier, and make decisions with confidence.
J. Paul Abernathy, a director of National Healthcare Corp. (NHC), reported exercising stock options and a related share withholding on August 13, 2025. He exercised options granted May 6, 2021, resulting in the acquisition of 4,010 shares at an exercise price implied by the filing of $71.64 per share. Simultaneously, 2,639 shares were withheld by the company to satisfy the exercise price, leaving Mr. Abernathy with 39,033 shares beneficially owned after the transactions. The filing lists outstanding option grants from 2022, 2023, 2024 and 2025, each covering 7,500 options with exercise prices from $69.19 to $96.03 and standard exercisability/expiration schedules.
Josh A. McCreary, Senior VP & General Counsel of National Healthcare Corp. (NHC), exercised stock options and reported related share withholding. On 08/13/2025 Mr. McCreary exercised 4,000 options with an exercise price of $53.94, resulting in 4,000 shares acquired. To cover the exercise price and withholding taxes, the company withheld 2,737 shares at an implied price of $108.82. After these transactions, Mr. McCreary beneficially owned 9,716 shares of NHC common stock.
The exercised options were part of a grant from the 2020 Omnibus Equity Incentive Plan issued on 03/08/2023 and are exempt from Section 16(b) under Rule 16b-3(d). The Form 4 was signed 08/15/2025 and reports both non-derivative and derivative holdings, including existing options exercisable through 2030.
National HealthCare Corporation (NHC) filed a Form 8-K dated 8 Aug 2025 reporting Item 8.01 – Other Events. The filing states that on 7 Aug 2025 the company issued a press release announcing its quarterly common-stock dividend. The press release is furnished as Exhibit 99.1 and is incorporated by reference. No dividend amount, record date, or payment date is disclosed within the 8-K itself, and no additional financial data or material transactions are presented.
National Healthcare Corp. (NHC) Form 4 filing dated 06/26/2025 reports a Code G gift by Sr. VP Patient Services Vicki L. Dodson.
Dodson transferred 788 common shares at $0, lowering her direct holdings from 9,748.5455 to 8,960.5455 shares. No cash sale occurred.
The filing also lists existing equity incentives:
- 3,734 options exercisable at $53.94 (expire 03/08/2028)
- 12,000 options at $94.10 (expire 03/05/2029)
- 13,500 options at $90.62 (expire 02/24/2030)
No other changes to ownership or control were disclosed. Given the small share count and gift classification, investment impact is minimal.
FAQ
What is the current stock price of National Health (NHC)?
What is the market cap of National Health (NHC)?
